The estimated Net Worth of Matt Scribner is at least $87.8 Tausend dollars as of 17 September 2018. Matt Scribner owns over 2,000 units of Inogen Inc stock worth over $87,798 and over the last 11 years Matt sold INGN stock worth over $0.
Matt has made over 48 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Matt exercised 2,000 units of INGN stock worth $1,620 on 17 September 2018.
The largest trade Matt's ever made was exercising 20,510 units of Inogen Inc stock on 17 August 2015 worth over $12,306. On average, Matt trades about 3,233 units every 29 days since 2014. As of 17 September 2018 Matt still owns at least 7,595 units of Inogen Inc stock.
You can see the complete history of Matt Scribner stock trades at the bottom of the page.
Matt's mailing address filed with the SEC is 326 BOLLAY DRIVE, , GOLETA, CA, 93117.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen und Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: